Inhibitory effect of Coptis chinensis on inflammation in LPS-induced endotoxemia

Journal of Ethnopharmacology

Volumn 149, Issue 2, 2013, Pages 506-512

  Choi, You Yeon ^a   Kim, Mi Hye ^a   Cho, Ik Hyun ^a   Kim, Ji Hee ^a   Hong, Jongki ^a   Lee, Tae Hee ^b   Yang, Woong Mo ^a  

^a Kyung Hee University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

Coptis chinensis; IL 6; Lipopolysaccharide (LPS); MAPKs; NF B

Indexed keywords

COPTIS CHINENSIS EXTRACT; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; COPTIS CHINENSIS; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; ENDOTOXEMIA; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; ETHNOPHARMACOLOGY; FEMALE; HEPATITIS; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

COPTIS CHINENSIS; MUS;

COPTIS CHINENSIS; IL-6; LIPOPOLYSACCHARIDE (LPS); MAPKS; NF-ΚB;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COPTIS; CYCLOOXYGENASE 2; ENDOTOXEMIA; FEMALE; HEPATITIS; I-KAPPA B PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RHIZOME;

EID: 84883177044     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.07.008     Document Type: Article

References (37)

1. R.C. Bone The sepsis syndrome: definition and general approach to management Clinics in Chest Medicine 17 1996 175 181
2. A.B. Carter, K.L. Knudtson, M.M. Monick, and G.W. Hunninghake The p38 mitogen-activated protein kinase is required for NF-kappa B-dependent gene expression. The role of TATA-binding protein (TBP) Journal of Biological Chemistry 274 1999 30858 30863
3. W.W. Chao, Y.H. Kuo, S.L. Hsieh, and B.F. Lin Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-[kappa] B trans-activation activity and LPS-induced acute inflammation in mice Journal of Ethnopharmacology 129 2010 244 249
4. C.C. Chow, G. Clermont, R. Kumar, C. Lagoa, Z. Tawadrous, D. Gallo, B. Betten, J. Bartels, G. Constantine, M.P. Fink, T.R. Billiar, and Y. Vodovotz The acute inflammatory response in diverse shock states Shock 24 2005 74 84
5. C.A. De la Lastra, and I. Villegas Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications Molecular Nutrition & Food Research 49 2005 405 430
6. A.L. DeFranco, J. Hambleton, M. McMahon, and S.L. Weinstein Examination of the role of MAP kinase in the response of macrophages to lipopolysaccharide Progress in Clinical and Biological Research 392 1995 407 420
7. B. Depboylu, M. Giriş, V. Olgaç, S. Doǧru- Abbasoǧlu, and M. Uysal Response of liver to lipopolysaccharide treatment in male and female rats Experimental and Toxicologic Pathology 65 2013 645 650
8. A.A. Dorai Wound care with traditional, complementary and alternative medicine Indian Journal of Plastic Surgery 45 2012 418 424
9. Y.B. Feng, W.Q. Luo, and S.Q. Zhu Explore new clinical application of Huang Lian and corresponding compound prescriptions from their traditional use Zhongguo Zhong Yao Za Zhi 10 2008 1221 1225
10. A. Francavilla, M. Hagiya, K.A. Porter, L. Polimeno, I. Ihara, and T.E. Starzl Augmenter of liver regeneration: it′s place in the universe of hepatic growth factors Hepatology 20 1994 747 757
11. S. Ghosh, and M.S. Hayden New regulators of NF-kappa B in inflammation Nature Reviews Immunology 8 2008 837 848
12. L.Y. Guo, T.M. Hung, K.H. Bae, E.M. Shin, H.Y. Zhou, Y.N. Hong, S.S. Kang, H.P. Kim, and Y.S. Kim Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill European Journal of Pharmacology 591 2008 293 299
13. C.Y. Hsiang, S.L. Wu, S.E. Cheng, and T.Y. Ho Acetaldehyde-induced interleukin-1b and tumor necrosis factor-a production is inhibited by berberine through nuclear factor-kB signaling pathway in HepG2 cells Journal of Biomedical Science 12 2005 791 801
14. I.N. Hsieh, A.S. Chang, C.M. Teng, C.C. Chen, and C.R. Yang Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways Journal of Biomedical Science 18 2011 28
15. D.A. Israf, T.A. Khaizurin, A. Syahida, N.H. Lajis, and S. Khozirah Cardamonin inhibits COX and iNOS expression via inhibition of p65 NF-κB nuclear translocation and Ik-B phosphorylation in RAW264.7 macrophage cells Molecular Immunology 44 2007 673 679
16. H. Kang, T.S. Bang, J.W. Lee, J.H. Lew, S.H. Eom, K. Lee, and H.Y. Choi Protective effect of the methanol extract from Cryptotaeniae japonica Hassk against lipopolysaccharide-induced inflammation in vitro and in vivo BMC Complementary and Alternative Medicine 12 2012 199
17. C.H. Lee, J.C. Chen, C.Y. Hsiang, S.L. Wu, H.C. Wu, and T.Y. Ho Berberine suppresses inflammatory agents-induced interleukin-1b and tumor necrosis factor-a productions via the inhibition of IkB degradation in human lung cells Pharmacological Research 56 2007 193 201
18. W.C. Lee, J.K. Kim, J.W. Kang, W.Y. Oh, J.Y. Jung, Y.S. Kim, H.A. Jung, J.S. Choi, and S.M. Lee Palmatine attenuates D-galactosamine/lipopolysaccharide- induced fulminant hepatic failure in mice Food and Chemical Toxicology 48 2010 222 228
19. B.R. Lin, C.J. Yu, W.C. Chen, H.S. Lee, H.M. Chang, Y.C. Lee, C.T. Chien, and C.F. Chen Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling Journal of Biomedical Science 16 2009 35 10.1186/1423-0127-16-35
20. S.F. Liu, and A.B. Malik NF-kappa B activation as a pathological mechanism of septic shock and inflammation American Journal of Physiology Lung Cellular and Molecular Physiology 290 2006 L622 L645
21. B.L. Ma, Y.M. Ma, C.L. Gao, J.S. Wu, F.R Qiu, C.H. Wang, and X.H. Wang Lipopolysaccharide increased the acute toxicity of the Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma coptidis alkaloids Journal of Ethnopharmacology 138 2011 169 174
22. B.L. Ma, Y.M. Ma, R. Shi, T.M. Wang, N. Zhang, C.H. Wang, and Y. Yang Identification of the toxic constituents in Rhizoma coptidis Journal of Ethnopharmacology 128 2010 357 364
23. J.H. Margaret, N. Sonja, J. Carol, and G. Aleksandr Inpatient care for septicemia or sepsis: a challenge for patients and hospitals National Center for Health Statistics 62 2011 1 8
24. A.F. Melamed, and J. Sorvillo The burden of sepsis-associated mortality in the United States from 1999 to 2005: analysis of multiple-cause-of-death data Critical Care 13 2009 R28
25. T. Nakama, S. Hirono, A. Moriuchi, S. Hasuike, K. Nagata, T. Hori, A. Ido, K. Hayashi, and H. Tsubouchi Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality Hepatology 33 2001 1441 1450
26. J.E. Parrillo, M.M. Parker, C. Natanson, A.F. Suffredini, R.L. Danner, R.E. Cunnion, and F.P. Ognibene Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy Annals of Internal Medicine 113 1990 227 242
27. G. Ramadori, J. Van Damme, H. Rieder, and K.H. Meyer zum Büschenfelde Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha European Journal of Immunology 18 1988 1259 1264
28. K. Reinhart, M. Bauer, N.C. Riedemann, and C.S. Hartog New approaches to sepsis: molecular diagnostics and biomarkers Clinical Microbiology Reviews 25 2012 609 634
29. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 Journal of Experimental Medicine 189 1999 1777 1782
30. S. Shinozaki, Y. Inoue, W. Yang, M. Fukaya, E.A. Carter, Y.M. Yu, A. Fischman, R. Tompkins, and M. Kaneki Farnesyl transferase inhibitor improved survival following endotoxin challenge in mice Biochemical and Biophysical Research Communications 391 2010 1459 1464
31. C.S. Sung, and C.S. Wong Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1β Acta Anaesthesiol Taiwan 45 2007 103 109
32. S.H. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of nitric oxide synthase and the down-regulation of the activation of NF kappaB in macrophages by resveratrol British Journal of Pharmacology 126 1999 673 680
33. Y. Vodovotz, J. Prelich, C. Lagoa, D. Barclay, R. Zamora, N. Murase, and C.R. Gandhi Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo, and in silico studies Molecular Medicine 18 2013 1421 1429
34. Y. Wan, P.D. Freeswick, L.S. Khemlani, P.H. Kispert, S.C. Wang, G.L. Su, and T.R. Billiar Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats Infection and Immunity 63 1995 2435 2442
35. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
36. Y. Yan, C. Chen, H. Zhou, H. Gao, L. Chen, L. Chen, L. Gao, R. Zhao, and Y. Sun Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats Research in Veterinary Science 3 2013 590 595
37. K.J. Yun, J.Y. Kim, J.B. Kim, K.W. Lee, S.Y. Jeong, J. Park, H.J. Jung, Y.W. Cho, K. Yun, and K.T. Lee Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways International Immunopharmacology 8 2008 431 441